36087-09-9

Basic information

• Product Name: H-L-HOMOLYS-OH HCL
• Synonyms: L-HOMOLYSINE HYDROCHLORIDE;H-L-HOMOLYS-OH HCL;H-L-HLys-OH*HCl;H-HLYS-OH 2HCL;H-LYS(*CH2)-OH 2HCL;L-Homolysine.HCl
• CAS NO: 36087-09-9
• Molecular Formula: C7H17ClN2O2
• Molecular Weight: 196.68
• Mol File: 36087-09-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: H-L-HOMOLYS-OH HCL(CAS DataBase Reference)
• NIST Chemistry Reference: H-L-HOMOLYS-OH HCL(36087-09-9)
• EPA Substance Registry System: H-L-HOMOLYS-OH HCL(36087-09-9)

Safety Data

• Hazardous Substances Data: 36087-09-9(Hazardous Substances Data)

Upstream product

• 146346-65-8 (3S,5S,6R)-3-(5-Iodo-pentyl)-2-oxo-5,6-diphenyl-morpholine-4-carboxylic acid benzyl ester 
• 628-77-3 1,5-diiodopentane 
• 78553-47-6 methyl (2S)-2-[N-(benzyloxycarbonyl)amino]pent-4-enoate 
• 862498-72-4 methyl (2S,4E/Z)-2-(benzyloxycarboxamido)-7-(tert-butoxycarboxamido)-4-heptenoate 
• 862498-74-6 methyl (2S)-2-amino-7-(tert-butoxycarboxamido)heptanoate 
• 146346-67-0 (3S,5S,6R)-3-(5-Azido-pentyl)-2-oxo-5,6-diphenyl-morpholine-4-carboxylic acid benzyl ester 

Relevant articles and documents

PEPTIDIC COMPOUNDS

The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.

An Efficient Asymmetric Synthesis of L-α,ω-Diaminoalkanoic acids

Efficient asymmetric syntheses of L-2,7-diaminoheptanoic acid and L-2,8-diaminooctanoic acid are described.